SCHEMBL24854647

SCHEMBL24854647

C=Cc1cc(N=O)cc(=O)n1C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11530183 0.75 GAA (0.34) GAA
SCHEMBL24853912 0.73 SMN1; SMN2 (0.36) GAA
SCHEMBL17366351 0.58 ALDH1A1 (0.36) —
SCHEMBL11527661 0.56 NQO2 (0.37) —
SCHEMBL18976219 0.56 GAA (0.38) GAA
SCHEMBL13823021 0.53 ALDH1A1 (0.58) —
SCHEMBL942919 0.53 ALDH1A1 (0.40) —
SCHEMBL24541493 0.53 ALDH1A1 (0.35) —
SCHEMBL21307503 0.53 HMGCR (0.31) —
SCHEMBL21344234 0.52 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4112620-A1 CYTISINE DERIVATIVES FOR THE TREATMENT OF ADDICTION The University of Bristol (GB) 2023-01-04 — — EP disclosed
Send feedback